| Metric | Q3 2026 | Q3 2025 |
|---|---|---|
| Revenue | 69.2 | 70.7 |
| Gross profit | 47.1 | 45.6 |
| Profit before tax | -0.1 | -10.6 |
| Net income | -0.9 | -11.0 |
| EPS (diluted, $ a share) | $-0.14 | $-1.74 |
A dash means the filing did not report that period. Growth is not shown when either period was a loss. Figures from the filing's XBRL data.
| Revenue, year on year | -2.1% |
|---|---|
| Gross margin | 68.2% |
| Operating margin | 7.2% |
10-Q filed with the SEC, NASDAQ: SKIN. Figures from the filing's XBRL data; summary written with AI assistance from the filing.
SkinHealth Systems Inc.: key numbers
- Share price
- $15.05Close, Nov 16
- Market cap
- $98.5M
- Shares outstanding
- 6.54MLatest SEC cover page
- Sector
- Industrial Applications and Services
- Industry
- Surgical & Medical Instruments & ApparatusSIC 3841
Today's reference numbers, updated daily. Not a valuation or a recommendation.
More from SkinHealth Systems Inc.
All →SkinHealth Systems Financial Results
SkinHealth Systems reported third quarter 2026 financial results, with net sales of $69.2 million and a significantly narrowed net loss of $0.9 million compared to $11.0 million in the prior year. The company highlighted a return to growth in consumables and improved adjusted EBITDA margins as it executes on strategic priorities for its flagship Hydrafacial brand.
- Term
- Q3 2026
“Our third quarter results reflect encouraging progress in strengthening our business. Revenue trends improved, consumables returned to growth, and we delivered healthy adjusted EBITDA performance. While we have more work ahead, these results give us greater confidence that the actions we are taking are moving the business in the right direction.”
Pedro Malha, President and Chief Executive Officer
SkinHealth Systems Reverse Stock Split
SkinHealth Systems Inc. implemented a 1-for-20 reverse stock split of its Class A Common Stock, effective October 14, 2026. The action is intended to help the company regain compliance with Nasdaq's $1.00 minimum bid price requirement. The split reduces the outstanding share count from approximately 130.3 million to 6.5 million shares.
SkinHealth Systems $103M Debt Financing with U.S. Bank National Association
SkinHealth Systems Inc. repaid in full the remaining $103.2 million aggregate principal amount of its 1.25% Convertible Senior Notes due 2026. Following the payment of principal and accrued interest, the related indenture was satisfied and discharged, releasing the company from its obligations under the notes.
- Value
- $103M
- Counterparty
- U.S. Bank National Association
SkinHealth Systems Reverse Stock Split
SkinHealth Systems stockholders approved an amendment to the company's Restated Certificate of Incorporation to implement a reverse stock split of its Class A Common Stock. The approved ratio range is between 1-for-5 and 1-for-20, with the final ratio to be determined by the board of directors.